Five β-diketone based Dy(iii) single-ion magnets (SIMs), [DyIII(TTA)3(AIP)]·0.5CH3CH2OH·0.5H2O (1), [DyIII(TTA)3(APIP)]·2CH3OH·H2O (2), [DyIII(TTA)3(DPP)] (3), [DyIII(TTA)3(BPP)]·0.5CH3CH2OH (4) and [DyIII(TTA)3(AIP)]·1.5H2O (5), were fully synthesized through alteration of their phenanthroline derivates (AIP = 2-(anthracen-9-yl)-1H-imidazo[4,5-f][1,10]phenanthroline, APIP = 2-(4-(anthracen-9-yl)phenyl)-1H-imidazo[4,5-f][1,10]phenanthroline, DPP = 2,3-diphenylpyrazino[2,3-f][1,10]phenanthroline and BPP = 2,3-bis(2,5-dimethylthiophen-3-yl)pyrazino[2,3-f][1,10]phenanthroline). Magnetic investigations reveal that all the complexes perform as SIMs, with notably different effective barriers of 69.4 K (1), 147.3 K (2), 122.1 K (3) and 234.2 K (4) in zero direct current (dc) field. Complexes of 2 and 4 possess almost twofold higher effective barriers compared to 1 and 3. By analyzing the crystal structures, the distinct magnetic dynamics was found to stem from the variation in intermolecular hydrogen bond interactions and charge delocalization of auxiliary ligands. With the help of ab initio calculations, a change of auxiliary ligand brings about varying intensities of quantum tunnelling magnetization (QTM), which account for the distinguishable magnetic dynamics. With a combination of experimental and theoretical analyses, this work provides a visual and instructive perspective to the understanding of fine tuning auxiliary ligands to design structurally modulated SIMs of mononuclear β-diketone dysprosium(iii) complexes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d0dt02864a | DOI Listing |
Mol Ther
January 2025
College of Veterinary Medicine, Jeonbuk National University, 79 Gobong-ro, Iksan City, Jeollabuk-do, 54596, Republic of Korea. Electronic address:
Cancer immunotherapy has revolutionized cancer treatment due to its precise, target-specific approach compared to conventional therapies. However, treating solid tumors remains challenging as these tumors are inherently immunosuppressive, and their tumor microenvironment (TME) often limits therapeutic efficacy. Interestingly, certain bacterial species offer a promising alternative by exhibiting an innate ability to target and proliferate within tumor environments.
View Article and Find Full Text PDFJ Transl Med
January 2025
Department of Immunology and Oncology, Centro Nacional Biotecnología (CNB-CSIC), Darwin, 3. Campus Universidad Autónoma de Madrid, 28049, Madrid, Spain.
Laminins (LMs) are a family of heterotrimeric glycoproteins that form the structural foundation of basement membranes (BM). By acting as molecular bridges between cells and the extracellular matrix (ECM) through integrins and other surface receptors, they regulate key cellular signals that influence cell behavior and tissue architecture. Despite their physiological importance, our understanding of the role of LMs in cancer pathobiology remains fragmented.
View Article and Find Full Text PDFJ Orthop Surg Res
January 2025
Xuzhou Medical University Affiliated Stomatology Hospital, Xuzhou, 221002, Jiangsu Province, China.
Purpose: We aimed to explore the mechanism by which Boron-doped nano-hydroxyapatite (B-nHAp) facilitates the proliferation and differentiation of osteoblasts through controlled release of B.
Methods: B-nHAp characterization was accomplished by means of X-ray diffraction, scanning electron microscopy, inductively coupled plasma mass spectrometry, and transmission electron microscopy. Human bone marrow mesenchymal stem cells (hBMSCs) were subjected to flow cytometry, alizarin red S staining, and cell counting kit-8 assay for proliferation and differentiation determination.
Breast Cancer Res
January 2025
Department of Cancer Biology, Loyola University Chicago Stritch School of Medicine, Maywood, IL, 50153, USA.
Resistance to endocrine therapies remains a major clinical hurdle in breast cancer. Mutations to estrogen receptor alpha (ERα) arise after continued therapeutic pressure. Next generation selective estrogen receptor modulators and degraders/downregulators (SERMs and SERDs) show clinical efficacy, but responses are often non-durable.
View Article and Find Full Text PDFNat Med
January 2025
Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
Huntington's disease (HD) is an autosomal dominant neurodegenerative disease with the age at which characteristic symptoms manifest strongly influenced by inherited HTT CAG length. Somatic CAG expansion occurs throughout life and understanding the impact of somatic expansion on neurodegeneration is key to developing therapeutic targets. In 57 HD gene expanded (HDGE) individuals, ~23 years before their predicted clinical motor diagnosis, no significant decline in clinical, cognitive or neuropsychiatric function was observed over 4.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!